Boeing 777X FAA Approval Boosts Stock, Clears Key Hurdle
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
The Federal Aviation Administration (FAA) granted Boeing approval to proceed with the next phase of flight tests for its 777X aircraft on 7 June 2026. This key certification milestone triggered a market response, sending Boeing's share price higher. The stock was trading at $215.45 as of 20:25 UTC today, up 2.31% for the session. The positive move extended a recent recovery from the day's low of $213.63.
The approval for extended testing marks the most significant positive development for the 777X program since the FAA lifted a flight restriction on the aircraft in late 2025. The last major certification hurdle cleared for a new Boeing widebody was for the 787-10, which received FAA type certification in January 2018 after approximately four years of flight testing. The current aerospace macro backdrop features strong demand for new, fuel-efficient long-haul aircraft from carriers like Emirates and Qatar Airways, though high interest rates continue to pressure airline capital expenditure decisions.
The catalyst for the FAA's decision was the successful completion of a rigorous series of initial flight tests and data reviews. Boeing engineers submitted thousands of hours of flight data to regulators, demonstrating the aircraft's handling characteristics and systems reliability. This data package satisfied a critical condition for moving beyond the initial, restricted flight envelope. The approval effectively de-risks the timeline for the remaining certification work, which includes extreme weather and system failure tests.
Boeing's stock gained $4.86 from its daily low to reach $215.45 on the news. The 2.31% intraday rise significantly outperformed the broader S&P 500 Industrials Sector, which was up only 0.4% for the same session. The company's market capitalization increased by approximately $3.1 billion based on the share price move. The 777X program itself represents over $50 billion in development costs and a backlog of more than 350 firm orders from airlines worldwide.
The approval narrows the gap to entry-into-service, which analysts now project for late 2027 or early 2028. Prior to this approval, some analysts had flagged a risk of further delays pushing initial deliveries into 2029. The current trading range for BA shares, between $213.63 and $218.37, reflects investor assessment of execution risk against the program's substantial future revenue potential. Boeing's year-to-date performance prior to this news was roughly flat, lagging the performance of key supplier Spirit AeroSystems.
| Metric | Before News (Approx.) | After News (Current) |
|---|---|---|
| BA Share Price | ~$210.50 (previous close) | $215.45 |
| Implied Certification Timeline | Late 2028/Early 2029 | Late 2027/Early 2028 |
| Program Execution Risk | High | Moderate |
The most direct beneficiaries are Boeing's major suppliers on the 777X program. Spirit AeroSystems, which builds the aircraft's composite fuselage, stands to see improved cash flow visibility. General Electric, the exclusive engine provider for the 777X with its GE9X turbofan, gains certainty around a major production ramp. European rival Airbus may face increased competitive pressure in the large twin-aisle segment, particularly for its A350-1000 model, though its order book remains solid for years.
A key limitation is that FAA approval for more flight tests is not the same as final type certification. The aircraft must still complete thousands of additional flight hours and pass stringent safety evaluations. The program's history of delays means skepticism among some credit analysts is warranted. Institutional positioning data indicates hedge funds had been increasing short interest in BA over the prior month, betting on further delays. The price action suggests a covering of some of these positions, contributing to the upward move.
The next defined catalyst is the completion of flutter testing, scheduled for the third quarter of 2026. Boeing must also complete function and reliability testing, a campaign often lasting several months, expected to start in early 2027. The definitive milestone will be the submission of the final type certification application to the FAA, likely in mid-2027.
Key levels for Boeing's stock include immediate resistance at the June high near $218.37. A sustained break above this level could target the 200-day moving average, currently around $225. Support is established at the day's low of $213.63 and stronger support at the $210 psychological level. For the program, watch for new order announcements from airlines like Lufthansa or Singapore Airlines, which would validate demand at projected list prices north of $400 million per aircraft.
It allows Boeing's test pilots to push the aircraft to its full performance limits, including maximum speed, altitude, and weight. This expanded envelope is required to gather data on how the plane behaves at its edges of operation, which is mandatory for certification. Previously, flights were restricted to a safer, narrower band of conditions. This step is a formal validation from regulators that the initial data is satisfactory and broader testing can proceed.
The 777X certification is following a more protracted timeline than the 787, which faced its own well-documented delays. The 787-8 achieved FAA type certification in August 2011, roughly three and a half years after its first flight. The 777X first flew in January 2020, and its path has been lengthened by the COVID-19 pandemic, engineering changes to the fuselage, and increased regulatory scrutiny on Boeing following the 737 MAX crises. The current pace is slower but under more intense FAA oversight.
It reduces Airbus's lead but does not eliminate it. Airbus has delivered over 1,000 A350 and A330neo aircraft combined, establishing a dominant position in the widebody market over the last decade. The 777X, with its larger capacity and longer range, targets a specific niche within that market. Boeing's ability to catch up depends on executing a flawlessly rapid certification from here and securing new orders beyond its current backlog, which is smaller than the A350's order book.
The FAA's green light materially de-risks the 777X timeline, shifting investor focus from perpetual delay to eventual delivery and revenue.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.